Dr. Alejandra Chávez-Santoscoy belongs to the NutriOmics research group
at the School of Engineering and Science from Tecnológico de Monterrey.
She was the Program Director of the Food Industry Engineering program at
Tecnológico de Monterrey, Campus Monterrey, and coordinated the ABET
accreditation of the Food Engineering Program. For more than 6 years,
she has been working on the phytochemistry and the functional effect of
phenolic compounds and other nutraceuticals, not only in vitro and
in vivo models but also in pilot clinical trials. Moreover, her research
has been focused on the design and evaluation of active ingredients,
mainly with the use of nanotechnology for the overproduction of active
compounds (harvest or post-harvest overproduction) or the stabilization
of components within a food, to support lipid and glucose metabolism.
Working with industry and social services are her main drivers in the
development of challenges related to Nutraceutical Discovery and
Functional Food Desing. Her innovative projects have earned her
international recognition as Innovators under 35 LatAm 2017 Recognition
by MIT Technology Review. She is a member of the National Researchers
Council, currently at Level 1. Member of the technical committee of the
National Network of Bionanotechnology focused on Public health,
veterinary medicine, food, and biosecurity.
Dr. Jonathan Javier Magaña-Aguirre obtained his Bachelor's Degree in Pharmacological Biologist Chemistry at the National Autonomous University of Mexico (UNAM) in 2002. He obtained an M.Sc. degree and Ph.D. degree in Genetics and Molecular Biology at CINVESTAV, México, in 2005 and 2008, respectively. He also has a diploma in Pharmaceutical administration. Immediately after obtaining his Ph.D., he entered as a researcher at the most important Reference Center for neuromuscular diseases in Mexico (National Rehabilitation Institute), where he quickly achieved his independence as a research group leader and was awarded the second highest ranking for Healthy Mexican researchers (Research in Medical Sciences level "E"). He belongs to the National Researchers Council as a Level 2 researcher (SNI 2) and is also a member of the Mexican Academy of Sciences. Also, he is a member of the steering committee of the Pan-American Hereditary Ataxia Network. From March 2020 to date, he has occupied the position of Head of the Bioengineering Department, Mexico City Region in Tecnológico de Monterrey. Finally, he has obtained multiple national and international awards, including "Esti¿mulo a las Investigaciones Me¿dicas Miguel Alema¿n Valde¿s" and "Premio de la Academia de Ciencias de Cuba".
Dr. Gerardo Leyva-Gómez has a Ph.D. in Chemical Sciences with a specialty in Pharmaceutical Technology from the National Autonomous University of Mexico (UNAM, 2014). He is currently a full professor in the Department of Pharmacy at UNAM. He has experience in the design of nanoparticles as potential vectors of drugs for neurodegenerative disorders regarding in vitro and in vivo models, and the modification and evaluation of new biopolymers for wound healing. He has published over 120 articles with more than 1500 citations (in Scopus) and received the principal science awards in Mexico.
